Haematologica
(Feb 2020)
SIRPαFc treatment targets human acute myeloid leukemia stem cells
- Oleksandr Galkin,
- Jessica McLeod,
- James A. Kennedy,
- Liqing Jin,
- Nathan Mbong,
- Mark Wong,
- Robert A. Uger,
- Mark D. Minden,
- Jayne S. Danska,
- Jean C.Y. Wang
Affiliations
- Oleksandr Galkin
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON;
- Jessica McLeod
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON,
- James A. Kennedy
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON,
- Liqing Jin
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON,
- Nathan Mbong
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON,
- Mark Wong
- Trillium Therapeutics Inc., Mississauga, ON,
- Robert A. Uger
- Trillium Therapeutics Inc., Mississauga, ON,
- Mark D. Minden
- Princess Margaret Cancer Centre, University Health Network, University of Toronto,
- Jayne S. Danska
- Hospital for Sick Children, University of Toronto, Toronto, ON
- Jean C.Y. Wang
- Princess Margaret Cancer Centre, University Health Network, University of Toronto,
- DOI
-
https://doi.org/10.3324/haematol.2019.245167
- Journal volume & issue
-
Vol. 106,
no. 1
WeChat QR code